Delayed recovery of destocked molecules
Two large commercial molecules under destocking may not return as expected; management declined to quantify value, creating uncertainty.
COHANCELIFESCIENCES / bear-case history
Track the concerns that keep returning.
Cohance Lifesciences · risk themes across the available quarters.
Research layer active
Bear-case history
Risks carried through the record.
high
Middle East logistics cost inflation
Geopolitical tensions have increased freight and raw material costs, expected to impact gross margins by 100-150 bps in Q1 FY27.
NJ Bio profitability timeline extended
NJ Bio's US facility expansion and bio conjugation capabilities will take >2 years to reach breakeven, delaying consolidated margin recovery.
Customer concentration in CDMO
Historical reliance on a few molecules led to revenue volatility; diversification is improving but still a risk.